Enjoy complimentary customisation on priority with our Enterprise License!
The automated breast ultrasound systems (abus) market size is forecast to increase by USD 666.5 million at a CAGR of 14.8% between 2023 and 2028.
The automated breast ultrasound systems (abus) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The diagnostic centers segment is estimated to witness significant growth during the forecast period.
Diagnostic centers serve as crucial institutions in the healthcare sector, utilizing various imaging techniques to assess a patient's health condition. These centers employ specialists who interpret imaging results, such as X-rays, mammograms, ultrasounds, and MRIs. The adoption of Advanced Breast Ultrasound Systems (ABUS) is increasing in these centers due to their ability to provide three-dimensional, real-time imaging of breast structures. GE Healthcare is one of the companies supplying ABUS to diagnostic centers, with installations like Invenia ABUS at South Central Regional Medical Center in June 2018. Radiologists and healthcare professionals use these advanced systems to detect breast lesions, particularly in women with dense breast tissue, which can be challenging to diagnose through mammography.
False positives can lead to unnecessary biopsies and anxiety for patients, making the sensitivity of imaging capabilities essential. ABUS can reduce false positives and improve diagnostic accuracy. Lifestyle factors, such as sedentary lifestyles, obesity, alcohol consumption, and smoking, contribute to an increased risk of breast cancer. Early detection through digital cancer screening, including mammography and ultrasound, is crucial for reducing breast cancer mortality. Wearable ultrasound devices and awareness campaigns are also gaining popularity as preventative care measures. Specialty centers and diagnostic imaging laboratories are other significant end-users of ABUS. Computer-aided detection and AI-based solutions are being integrated into imaging systems to enhance diagnostic accuracy and reduce workload for radiologists.
Extracorporeal therapeutic ultrasound and 3D imaging techniques are also evolving to provide more precise diagnoses. The diagnostic procedural volume continues to increase due to factors like the aging population, growing awareness, and expanding healthcare coverage. This trend is driving the demand for advanced imaging systems like ABUS, ensuring their role as a vital component of the diagnostic process.
Get a glance at the market report of share of various segments Request Free Sample
The Diagnostic centers segment was valued at USD 263.60 million in 2018 and showed a gradual increase during the forecast period.
Europe is estimated to contribute 31% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market size of various regions, Request Free Sample
In North America, the market for Advanced Breast Ultrasound (ABUS) systems holds a significant share due to several factors. The American Cancer Society and the Radiological Society of North America advocate for regular mammograms and breast examinations for women over 40, contributing to a high diagnostic procedural volume. The prevalence of breast cancer in the US is substantial, with it being one of the most common types of cancer, affecting over 279,000 women in 2020. This increasing incidence, coupled with breast cancer monitoring and guidance programs by government and private entities, drives the growth of the market.
Furthermore, the expansion of cancer-specialized hospitals and clinics, the emergence of breast cancer diagnostic centers, and the introduction of new ABUS products fuel market development. Healthcare professionals increasingly rely on advanced imaging techniques, such as three-dimensional imaging, real-time imaging, and 3D monochromatic images, to enhance diagnostic capabilities and improve sensitivity. AI-based solutions, computer-aided detection, and extracorporeal therapeutic ultrasound are also gaining popularity for their role in early detection and reducing false-positive biopsies. The market is further propelled by the growing awareness of breast health, preventative care programs, and digital cancer screening. Despite the benefits, challenges such as false positives, dense breast tissue, and obesity remain, necessitating continuous innovation in ABUS technology.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The automated breast ultrasound systems (abus) market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the automated breast ultrasound systems (abus) market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, automated breast ultrasound systems (abus) market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Becton Dickinson and Co. - The company specializes in advanced breast imaging technology, including automated ultrasound systems like Aceso. These systems leverage innovative imaging algorithms to provide precise, consistent results, enhancing diagnostic accuracy and improving patient care. By automating the ultrasound process, these systems reduce operator dependency and increase efficiency, making breast examinations more accessible and convenient for healthcare providers and patients alike.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Automated Breast Ultrasound Systems (ABUS) have emerged as a significant innovation in the diagnostic imaging market, offering enhanced capabilities for cancer detection in women with dense breast tissue. This technology utilizes high-frequency sound waves to generate three-dimensional monochromatic images, providing radiologists with more detailed and precise information than traditional handheld ultrasound. ABUS systems have gained popularity due to their ability to reduce false positives, a common issue with mammography. The sedentary lifestyle prevalent in many communities, coupled with an increase in lifestyle factors such as obesity and alcohol consumption, has led to a higher incidence of breast cancer. As a result, the demand for advanced screening tools like ABUS has grown.
The use of ABUS systems is not limited to diagnostic imaging centers; they are also being adopted by community health centers and hospitals. The technology's ability to offer real-time imaging and three-dimensional imaging techniques has made it an essential screening tool for breast lesions. The integration of AI-based solutions in ABUS systems has further enhanced their diagnostic capabilities. These systems can analyze large volumes of data and provide accurate results, reducing the workload on radiologists and improving overall efficiency. Despite the benefits, the adoption of ABUS systems faces challenges. The high cost of the technology and the need for skilled radiologists to interpret the images are significant barriers to widespread adoption.
Moreover, the debate around the necessity of elective surgeries and non-essential screenings, coupled with the fear of false-positive biopsies, has led to a cautious approach towards adopting new technologies. The market for ABUS systems is expected to grow as awareness programs and early detection initiatives gain traction. The increasing prevalence of breast cancer and the need for more accurate and less invasive diagnostic tools are driving the demand for ABUS systems. The integration of ABUS systems with digital cancer screening and wearable ultrasound devices is a promising trend. These advancements offer the potential for more accessible and convenient screening options, which could increase the adoption rate of the technology.
The role of healthcare professionals in promoting awareness and education about breast cancer and the importance of regular screenings cannot be overstated. The integration of ABUS systems into preventative care programs and specialty centers can lead to earlier detection and better outcomes for patients. In conclusion, the market for Automated Breast Ultrasound Systems is poised for significant growth, driven by the need for more accurate and less invasive diagnostic tools for breast cancer. The integration of AI-based solutions, real-time imaging, and three-dimensional imaging techniques offers the potential for improved diagnostic capabilities and increased efficiency. However, challenges such as cost and the need for skilled radiologists remain significant barriers to widespread adoption.
The role of healthcare professionals in promoting awareness and education about breast cancer and the importance of regular screenings is crucial in driving the adoption of ABUS systems.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
139 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 14.8% |
|
Market growth 2024-2028 |
USD 666.5 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
12.5 |
|
Key countries |
US, Germany, France, Japan, and Canada |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this automated breast ultrasound systems (abus) market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.